JPH06504279A - 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途 - Google Patents

欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途

Info

Publication number
JPH06504279A
JPH06504279A JP4502363A JP50236391A JPH06504279A JP H06504279 A JPH06504279 A JP H06504279A JP 4502363 A JP4502363 A JP 4502363A JP 50236391 A JP50236391 A JP 50236391A JP H06504279 A JPH06504279 A JP H06504279A
Authority
JP
Japan
Prior art keywords
tables
alkyl
formulas
chemical formulas
decane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP4502363A
Other languages
English (en)
Japanese (ja)
Inventor
ヒバート，　マルセル
ジットス，　マーリス　ダブリュ．
Original Assignee
メレルダウファーマス−ティカルズ　インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by メレルダウファーマス−ティカルズ　インコーポレイテッド filed Critical メレルダウファーマス−ティカルズ　インコーポレイテッド
Publication of JPH06504279A publication Critical patent/JPH06504279A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
JP4502363A 1990-12-24 1991-12-02 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途 Pending JPH06504279A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT90403757.9 1990-12-24
EP90403757 1990-12-24
PCT/US1991/008935 WO1992011011A1 (fr) 1990-12-24 1991-12-02 Utilisation de certains derives de glutarimide dans le traitement de la depression et des etats maniaques

Publications (1)

Publication Number Publication Date
JPH06504279A true JPH06504279A (ja) 1994-05-19

Family

ID=8205790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP4502363A Pending JPH06504279A (ja) 1990-12-24 1991-12-02 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途

Country Status (7)

Country Link
EP (1) EP0564520A1 (fr)
JP (1) JPH06504279A (fr)
KR (1) KR930702976A (fr)
AU (1) AU9134191A (fr)
CA (1) CA2097607A1 (fr)
HU (1) HU9301856D0 (fr)
WO (1) WO1992011011A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2552929C1 (ru) * 2013-11-14 2015-06-10 Общество С Ограниченной Ответственностью "Фарминтерпрайсез" Фармацевтическая композиция, содержащая производные глутаримидов, и их применение для лечения эозинофильных заболеваний

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361565A (en) * 1981-12-28 1982-11-30 Mead Johnson & Company 2-[4-[(4,4-Dialkyl-2,6-piperidinedion-1-yl)butyl]-1-piperazinyl]pyridines
AR241161A1 (es) * 1984-07-30 1991-12-30 Merrelll Dow Pharmaceuticals I "procedimiento para la preparacion de derivados n-aminoalquilen sustituidos de la glutarimida"
EP0191562B1 (fr) * 1985-01-23 1991-07-10 Glaxo Group Limited Dérivés de tétrahydrocarbazolones
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
DE3831888A1 (de) * 1988-09-20 1990-03-29 Troponwerke Gmbh & Co Kg Arzneimittel zur behandlung von apoplexia cerebri
EP0375819A1 (fr) * 1988-12-20 1990-07-04 Merrell Dow Pharmaceuticals Inc. Dérivés de 1,7'-[imidazo-[1,2-a]pyridin]5'-(6'H)ones

Also Published As

Publication number Publication date
KR930702976A (ko) 1993-11-29
EP0564520A1 (fr) 1993-10-13
CA2097607A1 (fr) 1992-06-24
AU9134191A (en) 1992-07-22
HU9301856D0 (en) 1993-09-28
WO1992011011A1 (fr) 1992-07-09

Similar Documents

Publication Publication Date Title
JP3494659B2 (ja) ５―（２―（４―（１，２―ベンゾイソチアゾール―３―イル）―１―ピペラジニル）―エチル）―６―クロロ―１，３―ジヒドロ―２（１ｈ）―インドール―２―オン（＝ジプラシドン）のメシラート二水和物塩、それらの製造、およびそれらのドーパミンｄ２拮抗薬としての使用
CA1285564C (fr) Derives de 1-¬1-(heteroaryl)piperazin-4-yl|pyrrolidine-2, 5-dione
JP6511430B2 (ja) がんの治療のための化合物および組成物
TW504506B (en) Substituted tetracyclic tetrahydrofuran derivatives
WO2016155545A1 (fr) Dérivé de 1,2,5-oxadiazole contenant un groupe sulfamyle, son procédé de préparation et son utilisation dans des produits pharmaceutiques
JPH09291034A (ja) 縮合ピリジン化合物およびその医薬としての用途
JPH054983A (ja) イソキノリノン誘導体、その製造方法およびその誘導体を有効成分として含有する５−ｈｔ３ レセプター拮抗剤
JPH06509576A (ja) アセチルコリンエステラーゼ阻害剤としてのキナゾリン誘導体
TW200301698A (en) Acridone inhibitors of IMPDH enzyme
ZA200503383B (en) 3,4,-Disubstituted pyrroles and their use in treating inflammatory diseases
JP2008543782A (ja) ５−ｈｔ１ａ受容体のピペラジン−ピペリジンアンタゴニストおよびアゴニスト
JP2010525024A (ja) 置換３−（４−ヒドロキシフェニル）−インドリン−２−オン化合物
JPH05125062A (ja) 新規三置換トリアジン化合物およびピリミジン化合物
ZA200204964B (en) 2-(1H-Indol-3-yl)-2-oxo-acetamides with antitumor activity.
JP4405732B2 (ja) β−カルボリン誘導体ならびにうつ病および不安に対する医薬的使用
JPH10226684A (ja) ニコチン様アセチルコリン受容体結合剤としての（ｎ−（ピリジニルメチル）−ヘテロサイクリック）イリデンアミン化合物
CA2345406A1 (fr) Analgesiques
JPH08504426A (ja) 新規の二環式ピリミジン化合物、それらの製造方法、およびそれらを含有する医薬組成物
JPH06504279A (ja) 欝病及び躁病の治療におけるある種のグルタルイミド誘導体の用途
JP2005516895A (ja) 腫瘍の治療のための２−アシルインドールの使用
KR20010022658A (ko) 3-치환된 3,4,5,7-테트라히드로-피롤로[3'4':4,5]티에노[2,3-ｄ]피리미딘 유도체, 그의 제법 및 5ｈｔ길항제로서의 용도
JP3199736B2 (ja) アミノアルキル置換された２−アミノ−５−メルカプトチアジアゾール、その製造及び使用
JP3873173B2 (ja) ビス−２−アミノピリジン類、その製造方法及び寄生虫感染を制御するためのその用途
JP6108696B2 (ja) インドールキノリン誘導体、該誘導体の製造方法、ならびに該誘導体を含有する抗マラリア剤および抗がん剤
JPH06506923A (ja) 抗癌性剤